Monographie - Isatuximab

Ultimo aggiornamento :
03/03/2026

Isatuximab

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Sarclisa

Argentina, Belgio, Finlandia, Francia, Germania, Giappone, Gran Bretagna, Irlanda, Italia, Lussemburgo, Messico, Norvegia, Romania, Spagna, Svezia, Svizzera, Ungheria

Bibliografia : Isatuximab

	tipo	pubblicazione
4617	Laboratorio	Isatuximab - SARCLISA 20mg/mL concentrate for solution for infusion - Summary of Product Characteristics - updated 16 August 2021 Sanofi Genzyme 2021
4956	Rivista	Vieillard V, Paul M. Stability of Isatuximab in NaCl Dilutions and Opened Vials Under Controlled and Excursion Conditions. Newsletter Stabilis 2025 ; 69: 2-9.
5131	poster	Vieillard V, Paul M. Stabilité d'isatuximab pur en flacon après ouverture ou en poche après dilution dans du NaCl, en conditions contrôlées et d'excursion. SFPO Congress, 15-17 October 2025, Saint-Malo, Fra 2025
5132	poster	Houssen M, Hindes E, Nicolaÿ S, Ruellou G, Forbin W, Jonathan K, Aouati H, Hu A, Combeau D, Antignac M, Sadou Yayé H. Evaluation of in-use physicochemical stability of diluted isatuximab (ISA). Gerpac Congress, 1-3 October 2025, Hyères, France 2025

Mentions Légales